Clinical Trials Logo
  1. Home
  2. Rotavirus Infection
  3. NCT01328925

Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

Rotavirus Infection Clinical Trial

Official title:
Double-blind, Placebo-controlled Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of nitazoxanide suspension compared to placebo in treating rotavirus disease in pediatric patients less than 6 years of age.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01328925
Study type Interventional
Source Romark Laboratories L.C.
Contact
Status Completed
Phase Phase 2
Start date December 2005
Completion date June 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT03207750 - This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine Phase 3
Completed NCT00895492 - Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile N/A
Completed NCT01266850 - Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules Phase 4
Completed NCT02992197 - The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity Phase 4
Completed NCT00981877 - Probiotics in the Management of Acute Rotavirus Diarrhea in Bolivian Children N/A
Completed NCT05032391 - Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization Phase 3
Active, not recruiting NCT02662543 - The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines N/A
Completed NCT00302640 - Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children Phase 2/Phase 3
Active, not recruiting NCT04626856 - Safety and Preliminary Immunogenicity Study of Inactivated Vaccine for Prevention of Rotavirus Infection Phase 1
Completed NCT01764256 - A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine Phase 1
Completed NCT00880698 - Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers Phase 2
Completed NCT00683982 - Use of Nitazoxanide and Probiotics in Acute Diarrhea Secondary to Rotavirus N/A
Completed NCT01511133 - Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™ N/A